- Home
- TCBX vs EBS Comparison
TCBX vs EBS Comparison
Compare TCBX & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBX
- EBS
- Stock Information
- Founded
- TCBX 2008
- EBS 1998
- Country
- TCBX United States
- EBS United States
- Employees
- TCBX N/A
- EBS N/A
- Industry
- TCBX Banks
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- TCBX Finance
- EBS Health Care
- Exchange
- TCBX Nasdaq
- EBS Nasdaq
- Market Cap
- TCBX 450.9M
- EBS 518.0M
- IPO Year
- TCBX 2021
- EBS 2006
- Fundamental
- Price
- TCBX $33.61
- EBS $10.20
- Analyst Decision
- TCBX Buy
- EBS Strong Buy
- Analyst Count
- TCBX 3
- EBS 3
- Target Price
- TCBX $25.33
- EBS $14.33
- AVG Volume (30 Days)
- TCBX 60.6K
- EBS 1.1M
- Earning Date
- TCBX 01-22-2025
- EBS 03-04-2025
- Dividend Yield
- TCBX N/A
- EBS N/A
- EPS Growth
- TCBX 38.69
- EBS N/A
- EPS
- TCBX 2.56
- EBS N/A
- Revenue
- TCBX $158,911,000.00
- EBS $1,125,500,000.00
- Revenue This Year
- TCBX N/A
- EBS $6.26
- Revenue Next Year
- TCBX $8.54
- EBS $2.42
- P/E Ratio
- TCBX $13.07
- EBS N/A
- Revenue Growth
- TCBX 17.73
- EBS 2.05
- 52 Week Low
- TCBX $18.00
- EBS $1.42
- 52 Week High
- TCBX $37.65
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- TCBX 51.35
- EBS 60.60
- Support Level
- TCBX $30.35
- EBS $9.20
- Resistance Level
- TCBX $33.53
- EBS $10.63
- Average True Range (ATR)
- TCBX 0.97
- EBS 0.67
- MACD
- TCBX 0.06
- EBS 0.05
- Stochastic Oscillator
- TCBX 73.74
- EBS 81.86
About TCBX Third Coast Bancshares Inc.
Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates eleven branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, and one branch in Detroit, Texas. The company has one segment, community banking, it generates most of its revenue from interest on loans, customer service, and loan fees.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.